Measurement of health status in patients with dizziness and a history of migraine

Journal of Neurologic Physical Therapy

Volumn 28, Issue 2, 2004, Pages 84-90

  Wrisley, Diane M ^a,c,d   Whitney, Susan L ^a,b,c   Furman, Joseph M ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33747420448     PISSN: 15570576     EISSN: 15570584     Source Type: Journal    
DOI: 10.1097/01.NPT.0000281188.71512.f5     Document Type: Article

References (48)

1. Cass SP, Furman JM, Ankerstjerne JKP, Balaban C, Yetiser S, Aydogan B. Migraine-related vestibulopathy. Ann Otol Rhinol Laryngol. 1997;106: 182-189.
2. Johnson GD. Medical management of migraine-related dizziness and vertigo. Laryngoscope. 1998;108: 1-28.
3. Marcus DA, Whitney SL, Furman JM. Treatment of migrainous vertigo. Expert Rev Neurotherapeutics. 2003;3: 307-316.
4. Furman JM, Marcus DA, Balaban CD. Migrainous vertigo: development of a pathogenic model and structured diagnostic interview. Curr Opin Neurol. 2003;16: 5-13.
5. Cohen HS, Kimball KT, Adams AS. Application of the vestibular disorders activities of daily living scale. Laryngoscope. 2000;110: 1204-1209.
6. Enloe LJ, Shields RK. Evaluation of health-related quality of life in individuals with vestibular disease using disease-specific and general outcome measures. Phys Ther. 1997;77: 890-903.
7. Wrisley DM, Whitney SL, Furman JM. Vestibular rehabilitation outcomes in patients with a history of migraine. Otology and Neurotology. 2002;23: 483-487.
8. Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36) I. Conceptual framework and item selection. Med Care. 1992;30: 473-483.
9. Wang S, Fuh J, Lu S, Juang K. Quality of life differs among headache diagnoses: analysis of SF-36 survey in 901 headache patients. Pain. 2001;89: 285-292.
10. McHorney CA, Ware JE, Lu JE, Sherbourne CD. MOS 36-item Short-Form Health Survey (SF-36): Tests of data quality, scaling assumptions, and reliability across divers patient groups. Med Care. 1994;32: 40-66.
11. Brazier JE, Harper R, Jones NMB, O’Cathain A, Thomas KJ, Usherwood T et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Br Med J. 1992;305: 160-164.
12. Jacobson GP, Newman CW. The development of the dizziness handicap inventory. Arch Otolaryngol Head Neck Surg. 1990;116: 424-427.
13. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27: S217-S232.
14. Solomon GD. Evolution of the measurement of quality of life in migraine. Neurology. 1997;48: S10-S15.
15. Dahlof C. Assessment of health-related quality of life in migraine. Cephalalgia. 1993;13: 233-237.
16. Lofland JH, Johnson NE, Batenhorst AS, Nash DB. Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective. Arch Intern Med. 1999;159: 857-863.
17. Monzon MJ, Lainez MJ. Quality of life in migraine and chronic daily headache patients. Cephalalgia. 1998;18: 638-643.
18. Osterhaus JT, Townsend RJ, Gandek B, Ware JE, Jr. Measuring the functional status and well-being of patients with migraine headache. Headache. 1994;34: 337-343.
19. Passchier J, de Boo HZA, Brienen JA. Health-related quality of life of chronic headache patients is predicted by the emotional component of their pain. Headache. 1996;36: 556-560.
20. Solomon GD, Skobieranda FG, Gragg LA. Quality of life and well-being of headache patients: measurement by the medical outcomes study instrument. Headache. 1993;33: 351-358.
21. Solomon GD, Skobieranda FG, Gragg LA. Does quality of life differ among headache diagnoses? Analysis using the medical outcomes study instrument. Headache. 1994;34: 143-147.
22. Solomon GD, Skobieranda FG, Genzen JR. Quality of life assessment among migraine patients treated with sumatriptan. Headache. 1995;35: 449-454.
23. Fielder H, Denholm SW, Lyons RA, Fielder C P. Measurement of health status in patients with vertigo. Clin Otolaryngol. 1996;21: 124-126.
24. Kuritzky A, Ziegler DK, Hassanein R. Vertigo, motion sickness, and migraine. Headache. 1981;21: 227-231.
25. Baloh RW. Neurotology of migraine. Headache. 1997;37: 615-621.
26. Ishiyama A, Jacobson KM, Baloh RW. Migraine and benign positional vertigo. Ann Otol Rhinol Laryngol. 2000;109: 377-380.
27. Kayan A, Hood JD. Neuro-otological manifestations of migraine. Brain. 1984;107: 1123-1142.
28. Litaker DG, Solomon GD, Genzen JR. Using pretreatment quality of life perceptions to predict response to suma-triptan in migraineurs. Headache. 1997;37: 630-634.
29. Neuhauser H, Lempert T. Vertigo and dizziness related to migraine: a diagnostic challenge. Cephalalgia. 2004;24: 83-91.
30. Ware JE, Snow K, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston, Mass: The Health Institute, New England Medical Center; 1993.
31. Ware JE, Kosinski M, Bayliss M, McHorney CA, Rogers WH, Raezek AE. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study. Med Care. 1995;33: AS264-AS279.
32. Portney LG, Watkins M P. Foundations of Clinical Research: Applications to Practice. Norwalk, Conn: Appleton and Lange; 1993.
33. Eagger S, Luxon LM, Davies RA, Coelho A, Ron MA. Psychiatric morbidity in patients with peripheral vestibular disorder: a clinical and neuro-otological study. J Neurol Neurosurg Psychiatry. 1992;55: 383-387.
34. Yardley L, Masson E, Verschuur C, Haacke N, Luxon L. Symptoms, anxiety and handicap in dizzy patients: development of the vertigo symptom scale. J Psychosom Res. 1992;36: 731-741.
35. Balaban CD, Porter JD. Neuroanatomic substrates for vestibulo-autonomic interactions. J Vestib Res. 1998;8: 7-16.
36. Balaban CD. Vestibular autonomic regulation (including motion sickness and the mechanism of vomiting). Curr Opin Neurol. 1999;12: 29-33.
37. Balaban CD, Thayer JF. Neurological bases for balance-anxiety links. J Anxiety Disord. 2001;15: 53-79.
38. Yardley L, Burgneay J, Nazareth I, Luxon L. Neuro-oto-logical and psychiatric abnormalities in a community sample of people with dizziness: a blind, controlled investigation. J Neurol Neurosurg Psychiatry. 1998;65: 679-684.
39. Yardley L. Overview of psychiologic effects of chronic dizziness and balance disorders. Otolaryngol Clin North Am. 2000;33: 603-616.
40. Silberstein SD, Lipton RB, Breslau N. Migraine: association with personality characteristics and psychopathology. Cephalalgia. 1995;15: 358-369.
41. Merikangas KR. Association betwen psychopathology and headache syndromes. Curr Opin Neurol. 1995;8: 248-251.
42. Stewart W, Breslau N, Keck PJ. Comorbidity of migraine and panic disorder. Neurology. 1994;44 (Suppl) 7: S23-S27.
43. Breslau N, Davis GC, Schultz LR, Peterson EL. Migraine and major depression: a longitudinal study. Headache. 1994;7: 387-393.
44. Jarman J, Fernandez M, Davies PTG, et al. High incidence of endogenous depression in migraine: confirmation by tyramine test. J Neurol Neurosurg Psychiatry. 1990;53: 573-575.
45. Breslau N, Davis GC. Migraine, major depression and panic disorder: a prospective epidemiologic study of young adults. Cephalalgia. 1992;112: 85-89.
46. Cutrer FM, Baloh RW. Migraine-associated dizziness. Headache. 1992;32: 300-304.
47. Yardley L, Putnam J. Quantitative analysis of factors contributing to handicap and distress in vertiginous patients: a questionaire study. Clin Otolaryngol. 1997;17: 231-236.
48. Whitney SL, Wrisley DM, Brown KE, Furman JM. Physical therapy for migraine-related vestibulopathy and vestibular-dysfunction with history of migraine. Laryngoscope. 2000;110: 1528-1534.